Header
Ihr Suchergebnis
Sie recherchieren derzeit unangemeldet.Melden Sie sich an (Login) um den vollen Funktionsumfang der Datenbank nutzen zu können.
Sie suchen in allen Bereichen nach dem Autor Bühler T.
In der Rubrik Zeitschriften haben wir 1 Beitrag für Sie gefunden
-
MerkenAdvanced Aseptic Pharmaceutical Production in a Scalable Isolator
Rubrik: Reinraum
(Treffer aus TechnoPharm, Nr. 02, Seite 86 (2023))
Advanced Aseptic Pharmaceutical Production in a Scalable Isolator / A Case Study · Lehmann F, Bühler T · SKAN AG, Allschwil (Switzerland) und Bausch+Stroebel Machine Company, Inc., Branford (USA)
Aseptic toxic isolator Modular fill-finish Small batch Advanced filling 100 % in-process-control Toxic/potent/high active The production processes in the pharmaceutical industry are increasingly changing in the direction of high-quality and highly specialized niche products [ 1 ]. Highly potent active pharmaceutical ingredients (HPAPIs) and Antibody Drug Conjugates (ADCs) for example are a new generation of highly active, pharmaceutical products, which are used for the targeted treatment of cancer. Some of these products require occupational safety measures that ensure compliance with occupational exposure limits below 100 ng/m 3 of air in the workplace [ 2 ]. Curia Albuquerque, NM/USA, is a pharmaceutical contract ...
